The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Long-term care facility (LTCF) cases and deaths were highest in the final two months of 2020 in many states, mirroring the spike in total COVID-19 case numbers and deaths this winter.
Arthur Allen, senior correspondent, writes about the FDA and the pharmaceutical industry as well as topics related to covid-19. He joined KFF Health News in 2020 after six years at Politico, where he created, edited, and wrote for its first news team to focus on health information technology. Previously, he was a freelance writer for publications such as The New York Times, The Washington Post, Smithsonian Magazine, and Slate. He also worked for The Associated…
While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes. In many ways the two groups face similar health risks from the virus, but nonelderly people with disabilities generally do not have the same high priority status for the vaccine, finds a new KFF analysis. As of early February…
This brief examines key policy challenges and issues related to distributing a COVID-19 vaccine in the U.S., including funding, supply and logistics, federal, state, and local authorities, insurance coverage, addressing racial and ethnic disparities, and communication and trust.
Government officials hope to identify one or more safe and effective COVID-19 vaccines over the next few months as part of a multi-agency effort known as Operation Warp Speed. If and when they succeed, their focus will shift to making sure people across the country can access the vaccine. A new issue brief lays out some of the key challenges with such a massive vaccination effort, which could require hundreds of millions of vaccine doses…
This brief summarizes the information contained in the all available draft COVID-19 vaccination plans submitted by states to the CDC, focusing in particular in critical areas such as identifying critical/priority populations, identifying and recruiting providers to administer vaccines, the completeness of state-level vaccine data collection and reporting systems, and communication plans. States report widely varying levels of progress.
As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
This updated analysis estimates that nationally at least 234,000 deaths from COVID-19 between June 2021 and March 2022 could have been prevented with a primary series of vaccinations. These vaccine-preventable deaths represent 60% of all adult COVID-19 deaths since June 2021, when vaccines first became widely available.
This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
To help inform ongoing global discussions about the creation of a new financing mechanism for pandemic preparedness and response, including questions about its governance and operations and the extent to which civil society will be formally included, we analyzed 14 major multilateral global health and related institutions to assess how civil society has been engaged in their governance, implementation/programming, and monitoring.
© 2026 KFF